These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28472610)

  • 21. Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis.
    Zack DJ; Stempniak M; Wong AL; Weisbart RH
    J Immunol; 1995 Nov; 155(10):5057-63. PubMed ID: 7594514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis.
    Suurmond J; Zou YR; Kim SJ; Diamond B
    Sci Transl Med; 2015 Mar; 7(280):280ps5. PubMed ID: 25810309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
    Martinsson K; Johansson A; Kastbom A; Skogh T
    Clin Exp Immunol; 2017 Apr; 188(1):53-62. PubMed ID: 27859022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
    Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
    J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Atehortúa L; Rojas M; Vásquez G; Muñoz-Vahos CH; Vanegas-García A; Posada-Duque RA; Castaño D
    Arthritis Res Ther; 2019 Jan; 21(1):34. PubMed ID: 30674349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies directed against ribosomal proteins in systemic lupus erythematosus and rheumatoid arthritis: a comparative study.
    Desbos A; Gonzalo P; Monier JC; Tebib J; Reboud JP; Perrier H; Bienvenu J; Fabien N
    Autoimmunity; 2002 Nov; 35(7):427-34. PubMed ID: 12685870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ternovoĭ KS; Gandzha IM; Babynina LIa; Volobueva ZV; Sukharenko NV; Dibrova TN; Selezneva TN; Ermekova VM
    Vrach Delo; 1990 Apr; (4):48-50. PubMed ID: 2275166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation.
    van de Stadt LA; de Vrieze H; Derksen NI; Brouwer M; Wouters D; van Schaardenburg D; Wolbink G; Rispens T
    Arthritis Rheumatol; 2014 May; 66(5):1133-40. PubMed ID: 24782178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
    Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
    Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.
    Weissbarth E; Baruth B; Mielke H; Liman W; Deicher H
    Rheumatol Int; 1982; 2(2):67-73. PubMed ID: 6217534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgGs containing light chains of the λ- and κ- type and of all subclasses (IgG1-IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin basic protein.
    Bezuglova AM; Konenkova LP; Buneva VN; Nevinsky GA
    Int Immunol; 2012 Dec; 24(12):759-70. PubMed ID: 22899672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ; Schur PH
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody.
    Hamasaki K; Mimura T; Kanda H; Morino N; Yazaki Y; Nojima Y
    Lupus; 1997; 6(9):734-6. PubMed ID: 9412990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sweet but dangerous - the role of immunoglobulin G glycosylation in autoimmunity and inflammation.
    Biermann MH; Griffante G; Podolska MJ; Boeltz S; Stürmer J; Muñoz LE; Bilyy R; Herrmann M
    Lupus; 2016 Jul; 25(8):934-42. PubMed ID: 27252272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.